Game Changing Solutions From Patient to Payor
Atomo helps you with the needs you express and then goes beyond to help you explore what you thought was impossible. Harness the power of big data, machine learning and other advanced analytics.
You Have Questions – We Have Solutions
Atomo leverages decades of healthcare and advanced analytics experience to provide powerful and time-tested solutions. These solutions are flexible and are optimized to meet your specific needs.
Pharmaceutical and Biotechnology
- How do I leverage limited resources to optimize my target universe?
- What is the highest unmet need that we address and which patient populations and HCPs meet that profile?
- What is our ideal patient profile and how do I best engage their HCPs?
- How do I grow my market by facilitating earlier diagnosis?
- How do I engage HCPs to raise awareness for undiagnosed and undertreated populations?
Research, Advocacy, & Policy Organizations
- Does our high need population have proper coverage for key treatments?
- What is the impact of restrictive coverage policies?
- How do we identify undiagnosed individuals with a specific medical condition?
- How many individuals in the U.S. have this high need profile?
- How are high patient out-of-pocket costs impacting our stakeholders?
Health Systems & Medical Groups
- How can we achieve optimal outcomes for our high need, high cost populations?
- How can we leverage our EHR to better inform our performance on guidelines and performance metrics?
Payers
- How can real world data inform our coverage and policy decisions?
- How can we find and interact early with high need, high cost populations?
- How can we use real world data to better understand/value our markets?
- How can we leverage our data to better partner with our providers?
Identifying and Engaging High-Need Populations
Atomo’s machine learning technology finds the critical, hidden patterns in digital healthcare records prior to patient diagnoses. Applying these learned patterns to the records of 200+ million patients identifies the patients with the highest unmet need.
- Undiagnosed Individuals
Atomo patient-finding technology has successfully identified undiagnosed patients for >8 diseases/conditions. - Diagnosed and High-Risk Individuals
Atomo methods find those patients at the highest risk and with the most to gain from appropriate treatment. - Segmenting, Prioritizing, and Targeting
Undiagnosed patients are grouped at different levels – to individual physicians, to geographic areas, etc – to facilitate efficient and HIPAA-compliant engagement.
Real World Examples
Finding Undiagnosed Familial Hypercholesterolemia (FH) patients
The Atomo team worked with Stanford and the Family Heart Foundation to find undiagnosed FH patients in Stanford’s health network. (published in Nature Digital Medicine) Read Paper Read Press Release
Identifying undiagnosed FH patients across the US population: the FIND FH ® algorithm
The Atomo team, working with the Family Heart Foundation, built a machine learning model to identify undiagnosed FH at the national scale. View Case Study
Real World Evidence Solutions
Our team utilizes real world data, including diagnosis, procedure, and prescription data from up to 200+ million individuals, to capture trends in the healthcare landscape and patient health outcomes.
- Market Access
Real world data at this scale can be used to quantify how payer utilization management policies affect market access and health outcomes. - Health Economics and Outcomes Research
Analyzing large real world data sets can be a cost-effective way to research outcomes.
Real World Examples
Restrictive payer policies have a negative health impact
Our team quantified the negative cardiac outcomes for patients who had a rejected or abandoned PCSK9i prescriptions. Read More
Utilization management policies found don’t account for high risk individuals in prescription rejections
The Atomo team, working with the Family Heart Foundation, revealed that individuals with high-risk conditions FH and ASCVD (Atherosclerotic Cardiovascular Disease) were rejected at the same rate as the general population. Read More
Patient Journey Analysis
Every patient’s journey from initial symptoms through diagnosis and therapy is unique. Our advanced analytics reveal each patient’s pathway including improvements to their health as well as setbacks and challenges. Patient journeys are then aggregated to reveal patterns such as the contrast between patient cohorts treated with different therapeutic agents.
- Timing and Pathway to Diagnosis
Atomo can reveal the pathways that lead to the fastest and most authoritative diagnosis. - Health Outcomes
Examination and quantification of patient health months or years after therapy provides a window into outcomes.
Real World Examples
A nationwide 2010-2012 analysis of U.S. health care utilization in inflammatory bowel diseases
To identify how specialty care can be improved, Atomo mapped current U.S. health care utilization in patients with inflammatory bowel diseases (IBD) using a national insurance claims database. Read Abstract
Reimagine Better Solutions
Atomo can help you leverage technology and big data to solve your most difficult healthcare challenges